180 related articles for article (PubMed ID: 8808216)
21. [Effect of calcitriol on secondary hyperparathyroidism].
Xu H; Zhang J; Cheng X; Zhou Q
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2013 Sep; 38(9):920-4. PubMed ID: 24071691
[TBL] [Abstract][Full Text] [Related]
22. Effect of calcitriol treatment and withdrawal on hyperparathyroidism in haemodialysis patients with hypocalcaemia.
Jara A; Chacón C; Valdivieso A; Aris L; Jalil R; Felsenfeld AJ
Nephrol Dial Transplant; 2001 May; 16(5):1009-16. PubMed ID: 11328908
[TBL] [Abstract][Full Text] [Related]
23. Intravenous 1,25(OH)2D therapy increases the intact parathyroid hormone secretion set point in hemodialyzed patients.
Brossard JH; Roy L; Lepage R; Gascon-Barré M; D'Amour P
Miner Electrolyte Metab; 1997; 23(1):25-32. PubMed ID: 9058366
[TBL] [Abstract][Full Text] [Related]
24. Intravenous calcitriol versus paricalcitol in haemodialysis patients with severe secondary hyperparathyroidism.
Abdul Gafor AH; Saidin R; Loo CY; Mohd R; Zainudin S; Shah SA; Norella KC
Nephrology (Carlton); 2009 Aug; 14(5):488-92. PubMed ID: 19298641
[TBL] [Abstract][Full Text] [Related]
25. Clinical effect of intravenous calcitriol administration on secondary hyperparathyroidism. A double-blind study among 4 doses.
Koshikawa S; Akizawa T; Kurokawa K; Marumo F; Sakai O; Arakawa M; Morii H; Seino Y; Ogata E; Ohashi Y; Akiba T; Tsukamoto Y; Suzuki M
Nephron; 2002 Apr; 90(4):413-23. PubMed ID: 11961400
[TBL] [Abstract][Full Text] [Related]
26. Safety and efficacy of pulse and daily calcitriol in patients on CAPD: a randomized trial.
Moe SM; Kraus MA; Gassensmith CM; Fineberg NS; Gannon FH; Peacock M
Nephrol Dial Transplant; 1998 May; 13(5):1234-41. PubMed ID: 9623560
[TBL] [Abstract][Full Text] [Related]
27. Serum parathyroid hormone suppression by intravenous 1,25-dihydroxyvitamin D3 in patients on maintenance haemodialysis.
Rassoul Z; Mousa D; Rehman MA; Abdalla AH; Hawas F; Popovich W; Gaisoum M; al-Sulaiman M; Al-Khader A
Am J Nephrol; 1995; 15(6):507-11. PubMed ID: 8546173
[TBL] [Abstract][Full Text] [Related]
28. Intermittent oral 1alpha-hydroxyvitamin D2 is effective and safe for the suppression of secondary hyperparathyroidism in haemodialysis patients. 1alphaD2 Study Group.
Frazao JM; Chesney RW; Coburn JW
Nephrol Dial Transplant; 1998; 13 Suppl 3():68-72. PubMed ID: 9568825
[TBL] [Abstract][Full Text] [Related]
29. Direct effect of the correction of acidosis on plasma parathyroid hormone concentrations, calcium and phosphate in hemodialysis patients: a prospective study.
Movilli E; Zani R; Carli O; Sangalli L; Pola A; Camerini C; Scolari F; Cancarini GC; Maiorca R
Nephron; 2001 Mar; 87(3):257-62. PubMed ID: 11287761
[TBL] [Abstract][Full Text] [Related]
30. Kinetics of serum 1,84 iPTH after high dose of calcitriol in uremic patients.
Seidel A; Herrmann P; Klaus G; Mehls O; Schmidt-Gayk H; Ritz E
Clin Nephrol; 1993 Apr; 39(4):210-3. PubMed ID: 8491051
[TBL] [Abstract][Full Text] [Related]
31. Effect of paricalcitol on circulating parathyroid hormone in X-linked hypophosphatemia: a randomized, double-blind, placebo-controlled study.
Carpenter TO; Olear EA; Zhang JH; Ellis BK; Simpson CA; Cheng D; Gundberg CM; Insogna KL
J Clin Endocrinol Metab; 2014 Sep; 99(9):3103-11. PubMed ID: 25029424
[TBL] [Abstract][Full Text] [Related]
32. The effect of peroral calcitriol in small doses on mild secondary hyperparathyroidism in patients on hemodialysis.
Pecovnik-Balon B
Am J Nephrol; 1995; 15(5):401-6. PubMed ID: 7503139
[TBL] [Abstract][Full Text] [Related]
33. Effect of dietary phosphorus on circulating concentrations of 1,25-dihydroxyvitamin D and immunoreactive parathyroid hormone in children with moderate renal insufficiency.
Portale AA; Booth BE; Halloran BP; Morris RC
J Clin Invest; 1984 Jun; 73(6):1580-9. PubMed ID: 6547151
[TBL] [Abstract][Full Text] [Related]
34. Effects of 22-oxacalcitriol and calcitriol on PTH secretion and bone mineral metabolism in a crossover trial in hemodialysis patients with secondary hyperparathyroidism.
Ogata H; Koiwa F; Shishido K; Takahashi K; Ito H; Kinugasa E; Taguchi S
Ther Apher Dial; 2007 Jun; 11(3):202-9. PubMed ID: 17498002
[TBL] [Abstract][Full Text] [Related]
35. Acute effects of repetitive hemodialysis on circulating immunoreactive parathyroid hormone levels in uremic patients undergoing vitamin D (calcitriol) therapy.
Bellazzi R; Romanini D; Bacchella L; Nai M; Aprile C; Santagostino M; De Vincenzi A
Nephron; 1991; 57(3):273-82. PubMed ID: 2017266
[TBL] [Abstract][Full Text] [Related]
36. Effect of CAPD and hemodialysis on parathyroid function.
Malberti F; Corradi B; Imbasciati E
Adv Perit Dial; 1996; 12():239-44. PubMed ID: 8865912
[TBL] [Abstract][Full Text] [Related]
37. High-dose oral calcitriol and zero calcium peritoneal solutions in CAPD patients with refractory secondary hyperparathyroidism.
Malberti F; Scanziani R; Corradi B; Dozio B; Bonforte G; Imbasciati E; Surian M
Nephrol Dial Transplant; 1994; 9(12):1813-5. PubMed ID: 7708273
[TBL] [Abstract][Full Text] [Related]
38. Comparison of treatments for mild secondary hyperparathyroidism in hemodialysis patients. Durham Renal Osteodystrophy Study Group.
Indridason OS; Quarles LD
Kidney Int; 2000 Jan; 57(1):282-92. PubMed ID: 10620210
[TBL] [Abstract][Full Text] [Related]
39. Effects of Denosumab and Calcitriol on Severe Secondary Hyperparathyroidism in Dialysis Patients With Low Bone Mass.
Chen CL; Chen NC; Liang HL; Hsu CY; Chou KJ; Fang HC; Lee PT
J Clin Endocrinol Metab; 2015 Jul; 100(7):2784-92. PubMed ID: 25955225
[TBL] [Abstract][Full Text] [Related]
40. Intravenous calcitriol lowers serum calcium concentrations in uraemic patients with severe hyperparathyroidism and hypercalcaemia.
Hamdy NA; Brown CB; Kanis JA
Nephrol Dial Transplant; 1989; 4(6):545-8. PubMed ID: 2507976
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]